Radiation Dose in Cancer Radiotherapy

Dear Colleagues,

More than half of cancer patients receive radiotherapy as part of their treatment and ongoing developments in the field have ensured that radiotherapy remains a key treatment option. Technological developments have seen the implementation of image guided, high precision treatments such as stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR) employing high dose, low fraction treatment regimens. The number of proton and carbon beam therapy facilities continues to rise globally and developments in molecular radiotherapy and brachytherapy have also been seen. Synergistic approaches using biological and immunotherapy agents are also being developed. These approaches have been supported by developments in preclinical investigations in small animal imaging and irradiation (SARP). All of these developments require accurate determination of the radiation dose to ensure clinical outcomes are not compromised. The aim of this special issue is to provide an up to date overview of developments in all aspects of Radiation Dose in Cancer Radiotherapy. 

Prof. Dr. Andrew Nisbet
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.